ERBB2 and breast cancer: In ERBB2+ breast cancers, high expression of PGC-1α predicts poorer prognosis and is correlated with high expression of glutamine cluster, reflecting the increased expression of PGC-1α in ERBB2+ breast cancer cells potentiates glutamine metabolism and facilitates proliferation under low glucose and hypoxia (88).